what is glp-1 drugs for weight loss Agonists: A Comprehensive Overview Another Weight-Loss Trial Win for

[DOI] [PMC free article] [PubMed] [Google Scholar] 67.Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Discussion Summary of findings In the present study, we found that the risk of MOF was slightly lower, albeit not significantly, in those treated with GLP-1 RA compared to those treated with DPP-4is as add-on therapies to metformin

However, the $2 billion+ deal between Hansoh and Merck highlights their strong confidence in the market prospects of HS-10535, adding fuel to the fire in the GLP-1 drug market

[DOI] [PubMed] [Google Scholar] 66.Shiraishi D, et al

The changes build on CVS Caremarks efforts as a pharmacy benefits manager to improve access to FDA-approved weight management therapies at more affordable costs

The STEP trials demonstrated that once-weekly semaglutide reduced body weight by 1418% over 68 weeks compared to 23% with placebo